Complete but not partial resection of glioblastoma promotes survival in the era of radiotherapy with concomitant and adjuvant temozolomide

Friedrich-Wilhelm Kreth, Niklas Thon, Bettina Hentschel, Torsten Pietsch, Michael Weller & Jörg-Christian Tonn
Objective: Resection followed by radiotherapy (RT) plus concomitant and adjuvant temozolomide (TMZ) is considered standard of care for glioblastoma. Treatment, however, is highly variable and the benefit of partial resection remains unclear. This multicenter observational study was conducted to assess[for full text, please go to the a.m. URL]